A phase I/II, multi-center, open-label study to assess the safety, tolerability and preliminary efficacy of a single intravenous dose of allogeneic mesenchymal bone marrow cells to subjects with ischemic stroke

2012-9141
Stroke
Steven Cramer
Open
INT - Drug
I/II
Adult
Local
For information about stem cell trials at UCI, please visit http://clinic.stemcell.uci.edu or call 949-824-3990 or email stemcell@uci.edu.
949-824-3990